Dr Raymond Chan
Chairman of the Board
MBBS MPH PhD FRACP FRCPA FFSc FAICD
Dr Chan is the Head of the Department of Infectious Disease at Royal Prince Alfred Hospital and the Microbiology laboratory at the RPA campus of the Sydney South West Pathology Service. He is a graduate of the University of Sydney from which he also received his Masters and PhD.
His previous roles include Director of the Royal College of Pathologists of Australasia through his role on Council as Councillor for NSW and as Chair of the (then) Board of Education. He recently completed a 20 year stint as an examiner in Microbiology for the RCPA.
He is a Clinical Senior Lecturer at the Sydney Medical School and teaches patient safety and quality to medical students. He is a member of the NSW Health Blood-borne virus Advisory Panel, the Medicare Participation Review committee, the Clinical Advisory Board of NSW Family Planning and the Medical Testing Accreditation Advisory committee of NATA and is the NATA/RPCA Liaison Officer. He chairs the Microbiology Clinical Stream of NSW Health Pathology.
Dr Lawrence Bott
MB, BS (Hons), FRCPA
Chief Executive Officer
Diagnostic Services Pty Ltd
Dr Bott is the Chief Executive Officer of Diagnostic Services Pty Ltd, Tasmania and Southern IML Pathology, NSW.
He trained as a general pathologist at Concord Hospital in Sydney. He has since had a long history of involvement in the provision of community pathology services. He has a particular interest in the development of computer systems to improve the quality of pathology result generation and reporting.
Previously he was a partner and pathologist at Barratt & Smith Pathology, becoming that organisation's Chief Executive Officer in 1995. Dr Bott has served on many committees for the Royal College of Pathologists of Australasia (RCPA) from 2000 to 2016, including as Honorary Secretary, Councillor for both NSW & Tasmania and Chair of the Board of Professional Practice and Quality. In 2013 he received the Meritorious Service Award from the RCPA. Currently, he is on the Board of the RCPA and has served on the Board of the QAP Pty Ltd for 16 years.
Dr John Rowell
MBBS MBA FRACP FRCPA GAICD
Director of Haematology
Queensland Health Pathology Service
Royal Brisbane and Womens Hospital Campus
Dr Rowell is Director of Haematology at Pathology Queensland and Director of the Queensland Haemophilia Centre, both based at the Royal Brisbane and Womens Hospital Campus. His major interests are in haemophilia and other bleeding disorders, genetics and transfusion.
His previous roles include Chairman of the Australian Haemophilia Centre Directors Organisation (AHCDO), member of the Council of the Australian and New Zealand Society of Blood Transfusion, Chairman of the RCPA Transfusion Quality Assurance Program and an examiner in Haematology for the Royal College of Pathologists of Australasia.
He is a Senior Lecturer at the University of Queensland, a Board Member of the Haemophilia Foundation Queensland and a member of the Pathology Clinical Committee of the Medicare Benefits Schedule Review Taskforce.
Dr Beverley Rowbotham
MBBS (Hons 1) MD FRACP FRCPA GAICD
Sullivan Nicolaides Pathology
Dr Rowbotham trained in Haematology in Brisbane and at the Mayo Clinic, Rochester, Minnesota. While her MD was awarded for work in thrombosis research, she maintains an active interest in all areas of diagnostic haematology. She is Director of Haematology with Sullivan Nicolaides Pathology in Queensland. She is an Associate Professor of Pathology at the University of Queensland.
She is a past President of the Royal College of Pathologists (2007-2009) and past President and Chair of the Association for Childhood Language and related Disorders (2001-2012).
She currently holds the positions of Federal Councillor for the Australian Medical Association (Pathology craft group) and Clinical Lead of Pathology for the National E Health Transition Authority. She is the Chair of the National Pathology Accreditation Advisory Council. She is a member of the Medicare Benefits Schedule Review Taskforce. Dr Rowbotham is also a Director of the Avant Mutual Group, the AEIOU Foundation and Genome One.
Dr Jeanne Tomlinson
MBBS FRCPA FIAC MBA
Department of Anatomical Pathology
ICPMR Westmead Hospital
Dr Tomlinson graduated from the University of Western Australia in 1990, receiving its Ten Seldam Gold Medal in Pathology. She obtained Fellowship of the Royal College of Pathologists of Australasia in 1997 and the International Academy of Cytology in 2000. She also attained a Masters in Business Administration at the University of New South Wales Australian Graduate School of Management in 2004. She has worked in both public and private sector laboratories, and is currently in private practice at Histopath Specialist Pathologists.
Dr Tomlinson has been a Director of the Royal College of Pathologists of Australasia through her roles on Council as Honorary Secretary and Treasurer. She is currently an examiner for the Royal College of Pathologists of Australasia in Anatomical Pathology.
Prof Anthony Landgren
MBBS LLB FRCPA FACLM MRACMA
MHSPS Royal Melbourne Hospital
Dept of Anatomical Pathology
Dr Landgren is the National Medical Director and Chief Pathologist at Australian Clinical Labs (formerly Healthscope Pathology). He is also Chairman of the Department of Anatomical Pathology at the Royal Melbourne Hospital. He trained in Anatomical and Forensic Pathology in Victoria and was admitted to Fellowship of the Royal College of Pathologists of Australasia in 1990. His subspecialty interests include head and neck pathology, hepatobiliary pathology, lung pathology, renal pathology and biotechnology law.
He has been admitted as a Barrister and Solicitor of the Supreme Court of Victoria. He is an Associate Professor of Pathology at the University of Melbourne. His previous roles include a solicitor in private practice and a health service manager with the Sisters of Mercy in Far North Queensland.
He is a Director of the Royal College of Pathologists of Australasia through his role as the Chair of the Board of Education and Assessment with responsibility for the training programs in all pathology disciplines, conduct of examinations, assessment of overseas trained specialists and laboratory accreditation for training for the College.
He is a member of the federal Department of Health’s Medical Training Review Panel and the Enhanced Medical Education Advisory Committee. He is a board member of the Victorian Cancer Biobank. He is also a Director of the Board of the National Association of Testing Authorities.
Dr Melody Caramins
BMed PhD FRCPA FFSc
Dr Caramins is the National Head of Genomic Diagnostics (SDS Pathology, Primary Healthcare). She is nationally recognised as an expert in the field of genetics, holding both medical and scientific specialist qualifications. She has a longstanding interest in improving patient care by integrating research, clinical and diagnostic activities. She is an active advocate for greater access to genetic testing.
She graduated from the University of Newcastle in 1992. She was awarded her Fellowship of the Royal College of Pathologists of Australasia in 2006 as Australia’s first graduate from the RCPA’s Genetic Pathology program.
In 2011, Dr Caramins was awarded her Doctor of Philosophy by the University of New South Wales for her thesis entitled “Fine mapping studies of quantitative trait loci for baseline platelet count in mice and humans.”
Her previous roles include four years as Acting Clinical Director, SEALS Genetics, (Prince of Wales, Sydney Children’s, and Royal Hospital for Women Campus) and a member of the Department of Health and Ageing Genetics Working Party
She is a Conjoint Senior Lecturer in the School of Medical Sciences at UNSW. She is currently a member of the Commonwealth Pathology Clinical Committee and Chair of the Royal College of Pathologists of Australasia’s Genetics Advisory Committee.